
Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.
Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.
Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.
Analytical characterization of biosimilars plays a crucial role in a successful path to regulatory approval.
ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.
Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.
According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.
The new research and development capacities set the stage for completion of product development for LEON’s manufacturing devices and will be used to showcase the devices and provide process development services to clients using LEON’s equipment.
In this article, a simple chromatographic model is proposed that is capable of predicting the impact of pH and ionic strength on HIC chromatograms.
Under a new partnership, Invitae and Deerfield Management will harness genetic and clinical testing data from patients to discover potential novel therapeutics for treating rare diseases.
Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.
Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.
Scientific Laboratory Supplies’ acquisition of C&M will bolster the company’s scientific calibration, maintenance, and validation offerings.
Agilent will work with Quest Diagnostics to distribute the ctDx FIRST test.
The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.
Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.
The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.
Advanced LC technologies can streamline the review process for LC equipment maintenance.
The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.
The R&D analytical solutions will consist of analytical lab services that use USP’s in-house scientific expertise and state-of-the-art facilities at the USP Advanced Manufacturing Technology Lab in Richmond and the USP headquarters facility in Rockville, Md.
Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.
An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Using a predictive modeling approach can help tighten up operator control over bioprocessing, which in turn can increase bioreactor output.
OGT has launched the SureSeq Myeloid Plus panel and OGT Universal NGS Complete Workflow.
An early drug candidate screening strategy should incorporate clear targets to lessen late-stage failure.
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.